Filtri
cris logo
-
Novo iskanje Filtri
Izberi iz seznama
Prikazano od Prikaži več
Dosegli ste najvišje možno število prikazanih rezultatov iskanja.
Prikazani so vsi rezultati
Za izvedeno iskanje ni na voljo rezultatov
Prikazano od
Dosegli ste najvišje možno število prikazanih rezultatov iskanja.
Prikazani so vsi rezultati
Nalaganje rezultatov
Pridobivanje statističnih podatkov

Mednarodni projekti vir: SICRIS

Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)

Uredi
Raziskovalci (3)
št. Evidenčna št. Ime in priimek Razisk. področje Vloga Obdobje Štev. publikacij
1.  01463  dr. Danijel Kikelj  Farmacija  Raziskovalec  2016 - 2020  566 
2.  15293  dr. Črtomir Podlipnik  Kemija  Raziskovalec  2016 - 2020  217 
3.  28334  dr. Tihomir Tomašić  Farmacija  Raziskovalec  2016 - 2020  374 
Organizacije (2)
št. Evidenčna št. Razisk. organizacija Kraj Matična številka Štev. publikacij
1.  0103  Univerza v Ljubljani, Fakulteta za kemijo in kemijsko tehnologijo  Ljubljana  1626990  23.099 
2.  0787  Univerza v Ljubljani, Fakulteta za farmacijo  Ljubljana  1626973  17.180 
Povzetek
The aim of this COST Action is to join highly-qualified research teams working in disciplines around the field of medicinal chemistry, into a novel network devoted to the multi-target issue in drug discovery. The choice of this theme is related to its marked multidisciplinary character, which can ensure a strong interaction among all COST Action participants. Currently, an important and emerging issue in modern drug discovery is to design novel or identify existing bioactive compounds, endowed with the capability to interact selectively with two or more macromolecular targets, exerting their effects against certain therapeutic goals in a synergic fashion. This leading concept stimulated this COST Action focusing on novel ligands able to recognize selected multiple targets, to promote closer scientific links among European research groups involved in medicinal chemistry field at both academic and industrial level. The research competencies of the network will span around medicinal chemistry, from synthetic chemistry, natural products and biophysics to theoretical chemistry, molecular modelling and biological screening.
Zahtevana je potrditev
Zgodovina ogledov
Priljubljeno